Scarica l'app Stockscreener
0.9193
1.16%
-0.0108
Precedente Chiudi:
$0.9301
Aprire:
$0.9298
Volume 24 ore:
57,814
Relative Volume:
0.59
Capitalizzazione di mercato:
$3.23M
Reddito:
$1.31M
Utile/perdita netta:
$-7.56M
Rapporto P/E:
-0.0893
EPS:
-10.2926
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
-10.75%
1M Prestazione:
-25.26%
6M Prestazione:
-59.50%
1 anno Prestazione:
-84.47%
Intervallo 1D:
$0.8967
$0.9888
Intervallo di 1 settimana:
$0.8967
$1.09
Portata 52W:
$0.8967
$8.62
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.9193 | 3.97M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
Degrees (SXTP) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; The Stock Finishes Near Unchanged in the Latest ReadingShare Dilution Risk - vinanet.vn
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating - Moomoo
SXTP Q1 2026 Earnings: Widened Loss of -$1.28 Per Share Misses Estimates as Stock Declines 5.77%Margin Improvement Report - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher, Holding Above $1.14 SupportOption Breadth - Vinanet
SXTP Q1 2026 Earnings: EPS Miss of 65.12% Exposes Pre-Revenue Pipeline Cost PressuresGross Profit Margin - vinanet.vn
60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan
60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade
ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan
60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Stock News Today - TradingKey
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals (NASDAQ: SXTP) reports 2026 shareholder vote outcomes - Stock Titan
Lind Global Fund III (SXTP) discloses 5.45% stake with warrant conversion cap - Stock Titan
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital - TipRanks
60 Degrees Pharmaceuticals Raises $1.0 Million in Private Placement of Stock and Warrants - tradingview.com
60 Degrees Pharmaceuticals (NASDAQ: SXTP) raises $1M in warrant-backed private placement - Stock Titan
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement - Bitget
SXTP Q1 2026 Earnings: Wider-Than-Expected Loss of $1.28 Per Share Sends Stock Down 16.11%Peak Earnings Alert - vinanet.vn
60 Degrees Pharmaceuticals raises $1M in private placement By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. announced that it has received $0.999618 million in funding - marketscreener.com
60 Degrees Pharmaceuticals Announces Minimum Enrollment - GlobeNewswire
60 Degrees Pharmaceuticals hits babesiosis trial enrollment milestone - scanx.trade
60 Degrees Pharmaceuticals Inc (SXTP) Balance Sheet - TradingKey
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.140| - TradingKey
60 Degrees Pharmaceuticals Secures US Patent for Tafenoquine Lung Infection Treatment - scanx.trade
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SXTP Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains UnreportedOne-Time Loss Impact - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Slips 0.67% as Stock Hovers Near SupportCommon Gap - dars.gov.et
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTP - TradingView
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals (SCTP) Proxy filing Summary - Quartr
60 Degrees Pharmaceuticals (SCTP) Registration Filing Summary - Quartr
60 Degrees Pharmaceuticals (SXTP) Holds Near Support as Selling Pressure EasesCovered Call ETF - vinanet.vn
60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update) – Minichart - Minichart
60 Degrees updates strategy for ARAKODA and profitability - TipRanks
SXTP Q1 2026 Earnings: EPS Misses Expectations as Company Navigates Pre-Revenue PhaseDividend Increase Stocks - vinanet.vn
Frontier tech research, news & data - MLQ.ai
SXTP Q1 2026 Earnings: Wider-Than-Expected Loss Amid No RevenuePost-Announcement Reaction - vinanet.vn
SXTP Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares LowerNegative Surprise Momentum - vinanet.vn
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 15 '25 |
Buy |
0.80 |
9,670 |
7,759 |
59,618 |
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):